Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade in Relapsed or Refractory Follicular B-Cell Lymphoma
NCT00136591Phase 2Terminated
- Sponsor
- Lymphoma Study Association
- Start
- Sep 2005
- Primary completion
- Jan 2010
- Modality
- Small Molecules, Modified Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), sponsored by Lymphoma Study Association. Started Sep 2005; status: terminated.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00136591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136591.